TP20 is superior to TP10 in reducing ischemia/reperfusion injury in rat lung grafts

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 948-949

  Schmid, R A ^a,b,c   Hillinger, S ^a,b,c   Hamacher, J ^a,b,c   Stammberger, U ^a,b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; TP10; TP20; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPLEMENT INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; ISCHEMIA; LUNG INJURY; LUNG TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATOR PROTEINS; DRUG COMBINATIONS; LIPID PEROXIDATION; LUNG; LUNG TRANSPLANTATION; OLIGOSACCHARIDES; PEROXIDASE; RATS; RATS, INBRED F344; RECEPTORS, COMPLEMENT; REPERFUSION INJURY;

EID: 0035080989     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02279-X     Document Type: Conference Paper

References (9)

1. Stammberger U, Carboni GL, Hillinger S, et al: J Heart Lung Transplant 18:862, 1999
2. Ohkawa H, Ohishi N, Yagi K: Anal Biochem 95:351, 1979
3. Fearon DT: Clin Exp Immunol 86(Suppl 1):43, 1991
4. Schmid RA, Zollinger A, Singer T, et al: J Thorac Cardiovasc Surg 116:90, 1998
5. Zamora MR, Davis RD, Keshavjee SH, et al: Chest 116(1 Suppl):46S, 1999
6. Naka Y, Toda K, Kayano K, et al: Proc Natl Acad Sci USA 94:757, 1997
7. Schmid RA, Yamashita M, Boasquevisque CH, et al: J Heart Lung Transplant 16:1054, 1997
8. Zacharowski K, Otto M, Hafner G, et al: Br J Pharmacol 128:945, 1999
9. Huang J, Kim LJ, Mealey R, et al: Science 285:595, 1999